94 Overall, the study indicated an improvement in PFS (hazard ratio=0.46) from the addition of lenalidomide although this did not reach statistical significance in the small subset of patients with MZL.
1
—
—
94 Overall, the study indicated an improvement in PFS (hazard ratio=0.46) from the addition of lenalidomide although this did not reach statistical significance in the small subset of patients with MZL.